	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	73.81	83.92	100.30	110.07	161.16	239.06	306.12	336.42	487.25	686.18	690.67	777.56	861.96
Cost of Operating Revenue	55.53	62.49	75.69	80.14	118.19	172.32	221.18	243.39	354.47	502.88	474.55	527.03	493.97
Gross Profit	18.28	21.43	24.61	29.93	42.97	66.74	84.94	93.02	132.78	183.30	216.12	250.53	367.99
Gross Margin	24.8	25.5	24.5	27.2	26.7	27.9	27.7	27.7	27.3	26.7	31.3	32.2	42.7
Total Operating Expenses	63.19	72.20	86.57	91.19	134.11	198.06	253.31	278.96	412.35	590.76	603.49	669.03	752.19
Operating Profit	10.62	11.72	13.73	18.88	27.05	41.00	52.81	57.46	74.90	95.42	87.18	108.53	109.77
Operating Margin	14.4	14.0	13.7	17.1	16.8	17.1	17.3	17.1	15.4	13.9	12.6	14.0	12.7
Financing Income/(Expense) - Net	-4.63	-4.04	-4.63	-7.36	-10.20	-11.83	-11.83	-13.68	-18.53	-25.11	-34.75	-46.93	-75.11
Profit before Taxes	6.19	8.07	8.48	11.51	17.34	29.25	41.10	44.22	57.07	71.03	52.77	50.16	41.08
Income Taxes	2.55	2.98	3.30	3.82	6.84	8.31	12.44	12.88	12.44	21.06	17.12	15.33	12.33
Profit after Tax	3.64	5.08	5.18	7.68	10.50	20.95	28.66	31.33	44.63	49.97	35.65	34.83	28.75
PAT Margin	4.9	6.1	5.2	7.0	6.5	8.8	9.4	9.3	9.2	7.3	5.2	4.5	3.3
EPS - Basic - ex Extraordinary Items	1.81	2.53	2.58	3.83	5.23	10.43	12.28	13.43	17.90	20.04	13.96	13.20	10.90
EPS - Diluted - ex Extraordinary Items	1.81	2.53	2.58	3.83	5.23	10.43	12.28	13.43	17.90	20.04	13.96	13.20	10.90
EBIT	10.62	11.72	13.73	18.88	27.05	41.00	52.81	57.46	74.90	95.42	87.18	108.53	109.77
EBITDA	11.54	12.66	14.73	20.19	28.99	43.83	58.05	64.36	86.59	111.62	110.05	136.32	137.29
EBITDA Margin	15.6	15.1	14.7	18.3	18.0	18.3	19.0	19.1	17.8	16.3	15.9	17.5	15.9

Balance Sheet

Abridged

Understanding Balance Sheet

Neogen Chemicals Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	PR	PR	PR	PR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	46	53	61	90	107	160	231	240	492	656	784	1,000	1,393
Long-Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	34
Property Plant & Equipment - Net	14	13	18	58	68	83	113	241	296	382	603	559	1,331
Total Non-Current Assets	17	16	20	63	74	87	124	252	307	398	678	747	1,509
Total Assets	63	69	80	152	180	246	355	492	799	1,054	1,461	1,747	2,902
Total Current Liabilities	37	38	46	67	84	117	150	174	218	410	527	733	1,188
Long Term Debt	5	5	5	37	38	51	38	122	123	134	138	194	868
Total Non-Current Liabilities	7	7	7	44	46	59	49	135	142	162	174	225	898
Total Liabilities	43	45	53	110	130	176	199	309	360	571	701	958	2,086
Total Shareholders' Equity	20	23	28	42	50	70	156	183	439	483	760	789	816
Total Equity	20	23	28	42	50	70	156	183	439	483	760	789	816
Total Liabilities & Equity	63	69	80	152	180	246	355	492	799	1,054	1,461	1,747	2,902

Cash Flow

Abridged

Understanding Cash Flow Statement

Neogen Chemicals Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	5.74	6.19	6.72	11.71	18.28	29.13	38.68	33.29	53.35	77.28	63.44	84.47	19.74
Working Capital - Increase/(Decrease)	-7.42	-2.14	-2.87	-18.14	-13.49	-42.63	-85.07	36.64	-70.08	-135.90	-128.76	64.74	-356.95
Net CF from Operating Activities	-1.69	4.05	3.85	-6.43	4.79	-13.51	-46.39	69.93	-16.73	-58.62	-65.32	149.21	-337.21
Capital Expenditures - Net	1.37	1.87	4.04	32.42	13.88	20.14	28.83	135.03	65.96	103.74	302.77	317.23	555.72
Net CF from Investing Activities	-1.37	-1.87	-4.04	-32.75	-13.84	-20.20	-28.72	-134.70	-146.77	-95.13	-222.89	-317.68	-413.73
Dividends Paid - Cash - Total	-	-	-	-	-	-	4.30	4.67	5.25	6.86	7.48	5.28	2.64
Stock - Issuance/(Retirement) - Net	-	1.30	-	10.70	-	-	70.00	-	225.00	-	246.65	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	4.13	-1.79	1.74	29.56	12.04	38.23	16.54	69.59	-4.16	136.09	39.42	166.19	754.35
Net Cash Flow from Financing Activities	3.07	-1.57	0.27	39.79	7.79	33.91	74.56	64.49	207.51	129.23	280.01	160.91	750.92
Free Cash Flow to Equity	1.07	0.39	1.55	-9.28	2.95	4.58	-58.68	4.49	-86.85	-26.27	-328.67	-1.83	-138.58
Free Operating CF net dividend	-3.06	1.84	-0.20	-38.85	-9.09	-33.65	-79.52	-69.77	-192.26	-169.22	-375.57	-173.78	-895.57
Free Operating CF	-3.06	1.84	-0.20	-38.85	-9.09	-33.65	-75.22	-65.10	-187.01	-162.36	-368.09	-168.50	-892.93

Business Segment Analysis

FY End:

Mar 25

Neogen Chemicals Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Bromine -based, and lithium-based, specialty chemicals (100.0%)₹ 317.71 Cr

Revenue / Sales

Bromine -based, and lithium-based, specialty chemicals (100.0%)₹ 777.56 Cr

Assets

Bromine -based, and lithium-based, specialty chemicals (100.0%)₹ 1,747.31 Cr

Operating Income

Bromine -based, and lithium-based, specialty chemicals (100.0%)₹ 108.53 Cr

Regional Segment Analysis

FY End:

Mar 25

Neogen Chemicals Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (71.9%)₹ 559.19 CrOverseas (28.1%)₹ 218.37 Cr

Historical Segment Analysis

Track how Neogen Chemicals Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Bromine -based, and lithium-based, specialty chemicals	29	135	170	104	303	318

Frequently Asked Questions

What is the revenue of Neogen Chemicals Ltd.?

The latest trailing twelve month revenue of Neogen Chemicals Ltd. is ₹ 861.96 Cr, reflecting a 1-year growth of 10.85% and a 3-year CAGR of 7.90%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Neogen Chemicals Ltd.?

The latest trailing twelve month net profit (PAT) of Neogen Chemicals Ltd. is ₹ 28.75 Cr, with a 3-year earnings CAGR of -18.37%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Neogen Chemicals Ltd.?

The trailing twelve month EBITDA of Neogen Chemicals Ltd. is approximately ₹ 109.77 Cr (based on an operating margin of 12.73%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Neogen Chemicals Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Neogen Chemicals Ltd. is 10.90. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Neogen Chemicals Ltd.?

The debt-to-equity ratio of Neogen Chemicals Ltd. stands at 1.71. The interest coverage ratio is 1.46x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Neogen Chemicals Ltd.?

The estimated book value per share of Neogen Chemicals Ltd. is 311.10 (derived from a P/B ratio of 6.54 and market price of ₹ 2,036.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Neogen Chemicals Ltd.?

The trailing twelve month operating cash flow of Neogen Chemicals Ltd. is ₹ -337.21 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Neogen Chemicals Ltd. report consolidated or standalone financials?

Neogen Chemicals Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.